On the action of botulinum neurotoxins A and E at cholinergic terminals.
Botulinum neurotoxins type A and E (BoNT/A and /E) are metalloproteases with a unique specificity for SNAP-25 (synaptosomal-associated protein of 25 kDa), an essential protein component of the neuroexocytotic machinery. It was proposed that this specificity is based on the recognition of a nine-residue sequence, termed SNARE motif, which is common to the other two SNARE proteins: VAMP (vesicle-associated membrane protein) and syntaxin, the only known substrates of the other six clostridial neurotoxins. Here we report on recent studies which provide evidence for the involvement of the SNARE motif present in SNAP-25 in its interaction with BoNT/A and /E by following the kinetics of proteolysis of SNAP-25 mutants deleted of SNARE motifs. We show that a single copy of the motif is sufficient for BoNT/A and /E to recognise SNAP-25. While the copy of the motif proximal to the cleavage site is clearly involved in recognition, in its absence, other more distant copies of the motif are able to support proteolysis. We also report on studies of poisoning human neuromuscular junctions with either BoNT/A or BoNT/E and describe the unexpected finding that the time of recovery of function after poisoning is much shorter in the case of type E with respect to type A intoxication. These data are discussed in terms of the different sites of action of the two toxins within SNAP-25.
Washbourne
P
P
Centro CNR Biomembrane, Università di Padova, Italy.
Pellizzari
R
R
Rossetto
O
O
Bortoletto
N
N
Tugnoli
V
V
De Grandis
D
D
Eleopra
R
R
Montecucco
C
C
D000818:Animals; D001905:Botulinum Toxins / Q000494:pharmacology* / Q000633:toxicity; D019274:Botulinum Toxins, Type A / Q000494:pharmacology* / Q000633:toxicity; D006801:Humans; D008565:Membrane Proteins; D051379:Mice; D016296:Mutagenesis; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D009498:Neurotoxins / Q000494:pharmacology* / Q000633:toxicity; D011994:Recombinant Proteins / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D017384:Sequence Deletion; D050825:Synaptosomal-Associated Protein 25
D008565:Membrane Proteins; D009419:Nerve Tissue Proteins; D009498:Neurotoxins; D011994:Recombinant Proteins; C494208:SNAP25 protein, human; C494209:Snap25 protein, mouse; D050825:Synaptosomal-Associated Protein 25; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A; C096326:botulinum toxin type E